Comparison of the difference between Librax and Duspatalin Retard tablets for the relief of irritable bowel syndrome symptoms

Both Librax and Duspatalin are used to relieve the symptoms of irritable bowel syndrome (IBS) and other functional gastrointestinal disorders, but they differ in the active ingredients they contain, their mechanism of action, and their specific uses. Understanding these differences helps determine the most appropriate medication for symptom relief.

Librax Tablets Ingredients

Librax tablets contain a combination of two active ingredients that work together to relieve IBS symptoms:

Chlordiazepoxide: A benzodiazepine, it is a mild sedative that helps reduce anxiety and tension, which can exacerbate IBS symptoms.

Clidinium Bromide: An anticholinergic, it works by relaxing the smooth muscles of the gastrointestinal tract, helping reduce cramps and pain associated with IBS.

Duspatalin Retard Tablets Ingredients

Duspatalin Retard tablets contain the active ingredient mebeverine hydrochloride. Mebeverine is an antispasmodic with a direct effect on the smooth muscles of the gastrointestinal tract. It selectively relaxes the intestinal muscles and relieves spasms and pain associated with irritable bowel syndrome (IBS) without interfering with normal bowel movements. Its "Retard" formulation means it releases the drug for a long-lasting effect.

About Librax Tablets

Drug Category: Combination medications for IBS

Drug Classification: Benzodiazepine and Anticholinergic

Drug Form: Tablets

Drug Family: Gastrointestinal Drugs, Central Nervous System Drugs

Active Ingredients: Chlordiazepoxide, Clidinium Bromide

About Duspatalin Retard Tablets

Drug Category: IBS

Drug Classification: Antispasmodic with a direct effect on smooth muscles

Drug Form: Sustained-Release Tablets (Retard)

Drug Family: Gastrointestinal Drugs

Active Ingredient: Mebeverine Hydrochloride

Author Name: Pharmacist Rawan Mossad Elsaed

Scientific Degree: Pharmacist

Country: Egypt

Dr. Rawan Mosaad El-Saeed is a clinical pharmacist and medical content reviewer holding a Bachelor of Pharmacy degree from Horus University in Egypt. She has hands-on community pharmacy experience in providing medication therapy counseling, monitoring drug-drug interactions, and ensuring patient adherence to safe usage protocols. She specializes in authoring and fact-checking pharmaceutical guides and simplifying clinical pharmacology based on the latest evidence-based guidelines and internationally accredited references, dedicated to delivering accurate, reliable, and safe healthcare information for readers.

Published Date: 19 April 2025